Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire

J Dermatol. 2020 Feb;47(2):e64-e65. doi: 10.1111/1346-8138.15148. Epub 2019 Nov 14.

Authors

Rie R Yotsu^{1

2}, Chiaki Murase³, Konan N'guessan⁴, Aubin Yao⁴, Kouamé Kouadio⁵, David Coulibaly N'Golo⁶, Aka N'Guetta⁶, Masashi Akiyama³, Kadio Constance⁷, Bamba Vagamon⁸

Affiliations

¹ Department of Dermatology, National Center for Global Health and Medicine, Shinjuku, Japan.
² School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
³ Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
⁴ MAP International West Africa, Abidjan, Côte d'Ivoire.
⁵ Eco Epidemiology Unit, Pasteur Institute Côte d'Ivoire, Abidjan, Côte d'Ivoire.
⁶ Department of Bacteriology and Virology, Pasteur Institute Côte d'Ivoire, Abidjan, Côte d'Ivoire.
⁷ Department of Dermatology-Infectiology, Treishville University Teaching Hospital, Abidjan, Côte d'Ivoire.
⁸ Raoul Follereau Institute Côte d'Ivoire, Adzopé, Côte d'Ivoire.

PMID: 31729074
DOI: 10.1111/1346-8138.15148

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibiotics, Antitubercular / therapeutic use*
Arm
Buruli Ulcer / diagnosis*
Buruli Ulcer / drug therapy
Buruli Ulcer / microbiology
Buruli Ulcer / pathology
Child
Cote d'Ivoire
Drug Therapy, Combination / methods
Humans
Male
Mass Screening / organization & administration*
Mycobacterium ulcerans / isolation & purification*
Neglected Diseases / diagnosis*
Neglected Diseases / drug therapy
Neglected Diseases / microbiology
Neglected Diseases / pathology
Rifampin / therapeutic use
School Health Services / organization & administration
Skin / microbiology
Skin / pathology
Streptomycin / therapeutic use
Treatment Outcome

Substances

Antibiotics, Antitubercular
Rifampin
Streptomycin

Grants and funding